Fig 1.
Summary of recruitment flow.
Table 1.
Baseline demographics of control and revascularized subjects.
Fig 2.
Box plot showing baseline (grey) and follow up (white) PV:isoSK-GFR characteristics in improver, stable and deteriorator kidneys.
*P<0.05 within group.
Table 2.
Comparison of imaging measurements between groups divided by renal functional outcome, comparing these outcome groups for stented ARVD kidneys and non-ARVD contralateral kidneys.
Between group statistical analysis is by ANCOVA.
Fig 3.
Percentage change in isoSK-GFR at 4 months post-revascularization grouped according to PV:isoSK-GFR ratio.
“High ratio” indicates those kidneys which had a PV:isoSK-GFR that exceeded the 95% CI for a given volume of a control kidney.
Table 3.
PV:isoSK-GFR characteristics of control kidneys used to establish 95% CI.
Fig 4.
Receiver operating characteristic curves for >15% improvement in isoSK-GFR following revascularization.
Dashed line represents isoSK-GFR (AUC 0.81). Solid line represents addition of PV:isoSK-GFR values (AUC 0.93).
Table 4.
Comparison of predicted versus actual outcomes for individual stented kidneys.
Fig 5.
Survival curves for revascularized patients divided into improvers versus non-improvers, and comparing with non ARVD control patients, adjusted for baseline age, co-morbidities, and GFR.